July 12, 2014 5:40 AM ET

Pharmaceuticals

Company Overview of Galleon Pharmaceuticals, Inc.

Executive Profile

Thomas John Dietz Ph.D.

Independent Director, Member of Audit Committee and Member of Compensation Committee, Transcept Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 6 different industries.

See Board Relationships
50$207,428

Background

Dr. Thomas John Dietz, Ph.D serves as the Chairman and Chief Executive Officer of Waypoint Holdings, LLC. Dr. Dietz served as a Co-Chief Executive Officer and Chief Executive Officer of Pacific Growth Equities, LLC. He served as the Head of the Investment Banking Division at Webush until November 2010. He served as Director of Equities Research at an award-winning biotechnology and biopharmaceutical analyst. He has more than 20 years of experience supporting the biopharma ...

Corporate Headquarters

213 Witmer Road
Horsham, Pennsylvania 19044

United States

Phone: 267-803-1970
Fax: 267-803-1971

Board Members Memberships

Director
Co-Chief Executive Officer, Director, Member of Operations Committee, and Member of Executive Committee
Director
Director
Director
2011-Present
Chairman
2013-Present
Independent Director, Member of Audit Committee and Member of Compensation Committee

Education

BS
State University of New York
PhD
Washington University, St. Louis

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$22,221
Unexercisable Options$22,779
Total Number of Options$45,000

Total Compensation

Total Annual Cash Compensation$33,261
Total Calculated Compensation$207,428
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin C. Gorman Ph.D.Chief Executive Officer, President and Director
Neurocrine Biosciences Inc.
$719.7K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$3.0M
Yasuchika Hasegawa Chairman of the Board and Chief Executive Officer
Takeda Pharmaceutical Company Limited
--
Mihael H. Polymeropoulos M.D.Founder, Chief Executive Officer, President and Director
Vanda Pharmaceuticals, Inc.
$515.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Galleon Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.